ADP-ribosyltransferases catalyze the transfer of the ADP-ribose moiety from NAD + onto proteins and other targets. These enzymes have been found in prokaryotes and in vertebrates; a eukaryotic enzyme structure is not yet known. The enzyme from Rattus norvegicus was expressed in the Escherichia coli periplasm at a level of about 0.2 mg per litre of culture, puri®ed and crystallized. Native data sets were collected to 2.0 A Ê resolution. A self-rotation function revealed a local twofold axis in crystal form A and a Patterson function showed a translational relationship in form B. Form C contains only one molecule in the asymmetric unit.
Introduction
ADP-ribosyltransferases (ART) transfer the ADP-ribose moiety of NAD + onto speci®c targets while releasing nicotinamide (Althaus et al., 1985; Aktories, 1991; Koch-Nolte & Haag, 1997) . The targets are mostly Arg, Cys, Asn or Glu residues of proteins. ADPribosylation is reversible and often profoundly affects protein function. Other targets are DNA, free amino acids, ADP-ribose itself and water. The enzyme group attracted interest as being bacterial toxins that, after being translocated into mammalian cells, ADP-ribosylate and inactivate key proteins such as G proteins, actin, ras, rho and elongation factor 2 (Aktories, 1991; Rappuoli & Montecucco, 1997) . The suspicion that these toxins mimic the function of mammalian homologues was nurtured by the discovery of ART activities in uninfected tissues. This initiated a search that revealed a small family of extracellular mammalian enzymes, including the GPIanchored membrane proteins, ecto-ART1 through ecto-ART4 and the secretory ecto-ART5 (Koch-Nolte & Haag, 1997; Okazaki & Moss, 1998) .
To date, the structures of eight bacterial ART toxins and of the distantly related nuclear poly(ADP-ribose)polymerase (PARP) from chicken are known (Rappuoli & Montecucco, 1997; Ruf et al., 1998; Han et al., 2001) , but no structure of a mammalian ecto-ART has been determined. Although the bacterial toxins and the mammalian ecto-ARTs exhibit less than 10% amino-acid identity, detailed sequence/ structure analyses made it very likely that they form one family (Domenighini & Rappuoli, 1996; Koch-Nolte et al., 1996; Bazan & Koch-Nolte, 1997; Pallen et al., 2001) .
The physiological functions of mammalian ecto-ARTs are still ill-de®ned. Mouse ART1 and ART2 ADP-ribosylate extracellular proteins: for instance, integrins and growth factors (Zolkiewska & Moss, 1995; Okamoto et al., 1998; Saxty et al., 2001) . R. norvegicus ART2.2 displays NAD + glycohydrolase and auto-ADP-ribosylation activities (Haag et al., 1995; Maehama et al., 1995) and gains arginine transferase activity by the exchange Q187E (Hara et al., 1996; Karsten et al., 1997; Maehama & Katada, 1997) . We focused on rat ART2.2 because it could be produced in the periplasm of E. coli and because it is the only non-glycosylated mammalian ecto-ART (Koch et al., 1990; Koch-Nolte & Haag, 1997) . The structure of this ART will provide a new starting point for functional studies.
Materials and methods

Expression and purification
In order to produce ART2.2, we tested expression systems based on insect cells (Sf9, Hi5), on mammalian cells (CHO, HEK) and on E. coli. Of these, only periplasmic E. coli expression was successful. The mammalian signal peptide (residues 1±20) was replaced by that of E. coli OmpA. Furthermore, the GPIanchor signal sequences were deleted by placing a stop codon behind Ser226.
The resulting gene, here called ART2.2, was cloned into plasmid pASK60 (Biometra) and expressed in E. coli NM522 cells. Freshly transformed E. coli NM522 cells were grown crystallization papers on agar plates. A single colony was picked and used to inoculate 10 ml Luria±Bertani broth supplemented with 50 mg ml À1 carbenicillin and 2 mM nicotinamide (LBCN broth). When the OD 600 reached 0.7, the cells were sedimented, resuspended in 2 ml fresh LBCN broth and used to inoculate 2 Â 400 ml LBCN broth. After 2 h of constant shaking at 310 K, the temperature was lowered to 293 K and the culture was grown for an additional 14 h. All further steps were performed at 277 K. Cells from 10 l of culture (25 Â 400 ml) were harvested, combined and subjected to osmolytic shock using lysis buffer [39 g sucrose, 25 mg Pefabloc SC (Fluka), 1.5 ml 0.5 M EDTA dissolved in 250 ml 0.1 M Tris±HCl pH 7.8].
After 60 min vigorous stirring, 250 ml water was added and stirring was continued for another 60 min. The lysate was clari®ed by centrifugation (48 000g, 60 min), dialyzed against buffer A (0.1 M Tris± HCl pH 7.5) and applied at 5 ml min À1 onto a pre-equili-brated (buffer A) Source-30S column (Pharmacia). The column was washed and the protein was eluted using a gradient of 0± 500 mM NaCl in buffer A. The ART2.2containing fractions were concentrated to less than 1 ml (Centriprep, Amicon) and run at 0.6 ml min À1 through a HighLoad16/ 60 Superdex-75 column using 150 mM NaCl in buffer A.
Crystallization and data collection
Crystallization was performed at 293 K using hanging drops. The protein was concentrated to 8.8 mg ml À1 (Millipore) and subjected to Crystal Screens I and II (Hampton Research), mixing equal volumes (2 ml) of the protein and the well solutions. Small crystals appeared at 100 mM Tris±HCl pH 8.5, 200 mM Li 2 SO 4 , 30%(w/v) PEG 4000. Re®nement resulted in good-quality crystals of two different morphologies with 100 mM Tris±HCl pH 8.3, 200 mM Li 2 SO 4 and 22%(w/v) PEG 4000 in the well. For storage, the PEG 4000 concentration was increased to 32%(w/v).
Increasing the glycerol concentration in ®ve steps, the crystals were transferred to a buffer containing 25%(v/v) glycerol, equilibrated for 2 min, mounted on cryoloops and then¯ash-frozen at 100 K using nitrogen gas (Cryostream, Oxford Cryosystems). Data were collected on an imaging plate (MAR Research) using graphite-®ltered Cu K radiation from a rotating-anode generator (model RU-200B, Rigaku) and processed using the programs MOSFLM (Leslie, 1992) , SCALA and TRUNCATE (Collaborative Computational Project, Number 4, 1994) .
Results and discussion
Expression of ART2.2 into the periplasm of E. coli NM522 cells secured the formation of the two potential disul®de bridges (Koch et al., 1990) . The periplasmic fraction was isolated by osmolysis and the protein was puri®ed using cation-exchange and gelpermeation chromatography. The yields ranged between 0.1 and 0.3 mg of ART2.2 per litre of culture. The protein was identi-®ed by N-terminal sequencing, which yielded the correct ®rst 12 amino-acid residues. Under the given crystallization conditions, we obtained three crystal forms suitable for X-ray diffraction analysis (Fig. 1) . They grew within 3±21 d. Forms A and B had identical crystal habits and their packing parameters (Matthews, 1968) indicated two ART2.2 molecules per asymmetric unit (Table 1) . In contrast, crystal 
Figure 2
Non-crystallographic symmetry of ART2.2 crystals. (a) The self-rotation function of crystal form A was calculated using POLARRFN (Collaborative Computational Project, Number 4, 1994) in the resolution range 20±2.5 A Ê with an integration radius of 10 A Ê . The contours are at 2, 3, F F F , 8'. (b) The Patterson map of crystal form B was calculated using all data in the resolution range 20±4 A Ê . Contouring is at 2, 3, 4, F F F , 16'. The origin and the translation peak heights are 84 and 26', respectively.
crystallization papers
form C contained only one molecule in the asymmetric unit. The addition of glycerol permitted data collection at 100 K. Crystal form A data were used for calculating a self-rotation function ( Fig. 2a ), which showed strong peaks at (3, 9, ) = (49, 0, 180 ) and (42, 180, 180 ) , indicating that the asymmetric unit contains two ART2.2 molecules related by a local twofold axis. Furthermore, a Patterson map of crystal form B (Fig. 2b) revealed a non-crystallographic translation described by the vector (0.5, 0.4, 0.0). The height of the corresponding peak amounts to 31% of that of the origin peak, indicating that the relationship is a rather exact translation. These analyses con®rmed the assignment of two molecules per asymmetric unit for crystal forms A and B (Table 1 ). The structure analysis of crystal form A is in progress.
